Data below comes from public STOCK Act disclosures. Filings are self-reported, may lag transactions by up to 45 days, and report amounts as ranges. Educational research only — not investment advice, and no implication of wrongdoing. New to this data? Read our guide.
About
Tommy Tuberville is a U.S. Senator from Alabama, serving since 2021.
Disclosure activity (last 12 months)
Disclosed trades
| Ticker | Type | Amount (disclosed range) | Traded | Disclosed | Filing |
|---|---|---|---|---|---|
 ABNDXAMERICAN FUNDS THE BOND FUND OF AMERICA | Buy | $50,001 - $100,000 | 2024-08-26 | 2026-08-05 | Official |
 GOOGLAlphabet Inc | Sell | $15,001 - $50,000 | 2025-10-07 | 2026-08-05 | Official |
 TXNTexas Instruments Inc | Sell | $15,001 - $50,000 | 2025-01-10 | 2026-08-05 | Official |
 CLFCleveland-Cliffs Inc | Sell | $100,001 - $250,000 | 2024-05-13 | 2026-08-05 | Official |
 CVSCVS Health Corp | Sell | $1,001 - $15,000 | 2024-08-26 | 2026-08-05 | Official |
 HONHoneywell International Inc | Sell | $15,001 - $50,000 | 2024-10-29 | 2026-08-05 | Official |
 TSCOTractor Supply Co | Sell | $15,001 - $50,000 | 2025-01-10 | 2026-08-05 | Official |
 WBAWalgreens Boots Alliance Inc | Buy | $15,001 - $50,000 | 2024-03-21 | 2026-08-05 | Official |
 MAMastercard Inc | Sell | $15,001 - $50,000 | 2025-04-15 | 2026-08-05 | Official |
 CTVACorteva Inc | Sell | $1,001 - $15,000 | 2024-10-29 | 2026-08-05 | Official |
 KMBKimberly-Clark Corp | Sell | $15,001 - $50,000 | 2024-10-29 | 2026-08-05 | Official |
 DUKDuke Energy Corp | Sell | $15,001 - $50,000 | 2025-04-15 | 2026-08-05 | Official |
 HUMAHUMACYTE INC (2) | Buy | $1,001 - $15,000 | 2024-03-21 | 2026-08-05 | Official |
 UPSUnited Parcel Service Inc | Sell | $15,001 - $50,000 | 2024-08-26 | 2026-08-05 | Official |
 INTCIntel Corp | Sell | $100,001 - $250,000 | 2024-05-13 | 2026-08-05 | Official |
 MDTMedtronic PLC | Sell | $15,001 - $50,000 | 2024-08-26 | 2026-08-05 | Official |
 DEODiageo PLC | Sell | $15,001 - $50,000 | 2025-01-10 | 2026-08-05 | Official |
 AMATApplied Materials Inc | Sell | $1,001 - $15,000 | 2024-03-08 | 2026-08-05 | Official |
 MSFTMicrosoft Corp | Sell | $15,001 - $50,000 | 2024-10-29 | 2026-08-05 | Official |
 CSXCSX Corp | Sell | $15,001 - $50,000 | 2025-04-15 | 2026-08-05 | Official |
 XBIState Street SPDR S&P Biotech ETF | Buy | $1,001 - $15,000 | 2024-05-08 | 2026-08-05 | Official |
 RYCEYRolls Royce Holdings PLC | Buy | $1,001 - $15,000 | 2024-03-21 | 2026-08-05 | Official |
 OCOwens Corning | Sell | $15,001 - $50,000 | 2024-10-29 | 2026-08-05 | Official |
 JPMJPMorgan Chase & Co | Sell | $1,001 - $15,000 | 2024-03-12 | 2026-08-05 | Official |
 LLYEli Lilly and Co | Sell | $15,001 - $50,000 | 2025-04-15 | 2026-08-05 | Official |
| GOOGLAlphabet Inc | Sell | $1,001 - $15,000 | 2025-12-17 | 2026-08-05 | Official |
 AAPLApple Inc | Sell | $15,001 - $50,000 | 2025-04-15 | 2026-08-05 | Official |
 NSRGYNestle SA, Cham Und Vevey | Sell | $15,001 - $50,000 | 2024-10-29 | 2026-08-05 | Official |
| CSXCSX Corp | Sell | $15,001 - $50,000 | 2024-03-12 | 2026-08-05 | Official |
 JNJJohnson & Johnson | Sell | $15,001 - $50,000 | 2024-10-29 | 2026-08-05 | Official |
| JPMJPMorgan Chase & Co | Sell | $15,001 - $50,000 | 2025-04-15 | 2026-08-05 | Official |
 STZConstellation Brands Inc | Sell | $15,001 - $50,000 | 2025-04-15 | 2026-08-05 | Official |
 EIBLXEaton Vance Floating Rate I | Sell | $50,001 - $100,000 | 2024-08-26 | 2026-08-05 | Official |
 QCOMQUALCOMM Inc | Sell | $15,001 - $50,000 | 2025-04-15 | 2026-08-05 | Official |
| XBIState Street SPDR S&P Biotech ETF | Buy | $1,001 - $15,000 | 2024-05-08 | 2026-08-05 | Official |
 ADBEAdobe Inc | Sell | $15,001 - $50,000 | 2024-10-29 | 2026-08-05 | Official |
 ARKKARK Innovation ETF | Buy | $1,001 - $15,000 | 2024-05-10 | 2026-08-05 | Official |
| WBAWalgreens Boots Alliance Inc | Buy | $15,001 - $50,000 | 2024-03-21 | 2026-08-05 | Official |
 ADMArcher-Daniels-Midland Co | Sell | $15,001 - $50,000 | 2025-04-15 | 2026-08-05 | Official |
| CLFCleveland-Cliffs Inc (6) | Buy | $1,001 - $15,000 | 2024-05-10 | 2026-08-05 | Official |
| ADBEAdobe Inc (4) | Sell | $1,001 - $15,000 | 2024-03-13 | 2026-08-05 | Official |
| AAPLApple Inc | Sell | $15,001 - $50,000 | 2025-10-07 | 2026-08-05 | Official |
 GILDGilead Sciences Inc (3) | Buy | $1,001 - $15,000 | 2024-05-10 | 2026-08-05 | Official |
 TRVThe Travelers Companies Inc | Sell | $15,001 - $50,000 | 2024-10-29 | 2026-08-05 | Official |
| MDTMedtronic PLC | Sell | $15,001 - $50,000 | 2024-08-26 | 2026-08-05 | Official |
| EIBLXEaton Vance Floating Rate I | Sell | $50,001 - $100,000 | 2024-08-26 | 2026-08-05 | Official |
| AAPLApple Inc | Sell | $15,001 - $50,000 | 2025-01-10 | 2026-08-05 | Official |
| INTCIntel Corp | Sell | $100,001 - $250,000 | 2024-05-10 | 2026-08-05 | Official |
| HUMAHUMACYTE INC | Buy | $15,001 - $50,000 | 2024-03-21 | 2026-08-05 | Official |
| GOOGLAlphabet Inc | Sell | $15,001 - $50,000 | 2025-04-15 | 2026-08-05 | Official |
Data last updated 2026-08-05. Amounts show the disclosed range verbatim.
Frequently asked questions
How many stock trades has Tommy Tuberville disclosed recently?
Tommy Tuberville has 172 disclosed securities transactions in the last 12 months of STOCK Act filings tracked by Valarn. Each filing links to the official disclosure document.
What stocks has Tommy Tuberville traded most?
The most frequent tickers in Tommy Tuberville's recent disclosures are AAPL, CLF, MSFT, CSX, GOOGL. Amounts are reported in ranges, and disclosures may lag the underlying transaction by up to 45 days.
When was Tommy Tuberville's most recent disclosure?
The most recent disclosed filing tracked here is dated 2026-08-05. New filings are ingested hourly as the House and Senate publish them.
Where does this data about Tommy Tuberville come from?
From public STOCK Act disclosures published by the U.S. House and Senate, and the public-domain congressional roster. Every trade row links to the official filing. Educational research only — not advice, and no implication of wrongdoing.
Related members
Research any stock with up to 25 AI agents
Valarn folds congressional disclosures, insider activity, filings, and market data into one research report — educational, transparent, never advice.
Portrait: public domain, via the unitedstates project.